1. Home
  2. VOXR vs CDXS Comparison

VOXR vs CDXS Comparison

Compare VOXR & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOXR
  • CDXS
  • Stock Information
  • Founded
  • VOXR 2014
  • CDXS 2002
  • Country
  • VOXR United States
  • CDXS United States
  • Employees
  • VOXR N/A
  • CDXS N/A
  • Industry
  • VOXR Precious Metals
  • CDXS Major Chemicals
  • Sector
  • VOXR Basic Materials
  • CDXS Industrials
  • Exchange
  • VOXR Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • VOXR 168.0M
  • CDXS 201.3M
  • IPO Year
  • VOXR N/A
  • CDXS 2010
  • Fundamental
  • Price
  • VOXR $3.23
  • CDXS $2.82
  • Analyst Decision
  • VOXR
  • CDXS Buy
  • Analyst Count
  • VOXR 0
  • CDXS 2
  • Target Price
  • VOXR N/A
  • CDXS $11.00
  • AVG Volume (30 Days)
  • VOXR 860.4K
  • CDXS 940.7K
  • Earning Date
  • VOXR 08-06-2025
  • CDXS 08-07-2025
  • Dividend Yield
  • VOXR 1.53%
  • CDXS N/A
  • EPS Growth
  • VOXR N/A
  • CDXS N/A
  • EPS
  • VOXR N/A
  • CDXS N/A
  • Revenue
  • VOXR $10,845,445.00
  • CDXS $49,815,000.00
  • Revenue This Year
  • VOXR $16.51
  • CDXS $12.53
  • Revenue Next Year
  • VOXR $4.60
  • CDXS $22.54
  • P/E Ratio
  • VOXR N/A
  • CDXS N/A
  • Revenue Growth
  • VOXR N/A
  • CDXS N/A
  • 52 Week Low
  • VOXR $2.21
  • CDXS $1.90
  • 52 Week High
  • VOXR $3.79
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • VOXR 46.91
  • CDXS 55.49
  • Support Level
  • VOXR $3.13
  • CDXS $2.77
  • Resistance Level
  • VOXR $3.39
  • CDXS $3.12
  • Average True Range (ATR)
  • VOXR 0.14
  • CDXS 0.20
  • MACD
  • VOXR 0.00
  • CDXS 0.01
  • Stochastic Oscillator
  • VOXR 48.72
  • CDXS 59.26

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: